Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation

Omar Ahmad1, Timothy N Crawford2, Vaneet Arora3

  • 1Division of Infectious Diseases, University of Kentucky, 740 S. Limestone Street K512, Lexington, 40536, KY, USA.

Insights

Hypoalbuminemia and high ATLAS scores in patients with Clostridioides difficile infection (CDI) may predict severe complications like shock or ileus. These findings are crucial for identifying high-risk patients on optimal therapy.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Clostridioides difficile infection (CDI) poses significant risks, with traditional risk factors identified in patients on older treatment regimens.
  • Reassessing risk factors like hypoalbuminemia and elevated ATLAS scores is crucial for patients receiving current optimal CDI therapy.

Purpose of the Study:

  • To re-evaluate risk factors for severe and fulminant Clostridioides difficile infection (CDI) in patients treated with optimal therapy.
  • To identify predictors of critical illness progression in hypotensive CDI patients.

Main Methods:

  • Retrospective review of hospitalized adult patients with CDI.
  • Classification of patients into non-severe/severe and fulminant CDI groups, with further subdivision of fulminant cases.
  • Correlation analysis to assess relationships between clinical variables and disease severity.

Main Results:

  • Declining albumin levels and increasing ATLAS scores correlated with worsening disease severity in fulminant CDI.
  • Low albumin (< 20 g/L) and high ATLAS scores (≥ 6) were significant predictors of critical illness in hypotensive patients.
  • WBC counts were similar between fulminant subgroups, but albumin and ATLAS scores differed.

Conclusions:

  • Hypoalbuminemia and high ATLAS scores are potential early indicators of progression to shock, ileus, or megacolon in hypotensive CDI patients.
  • These markers may aid in risk stratification and timely intervention for severe CDI.
  • Findings emphasize the importance of albumin levels and ATLAS scores in managing CDI patients on optimal therapy.
Abstract